science 🧪 Melbourne joins global drug discovery effort
The University of Melbourne has joined the Structural Genomics Consortium, creating SGC-Melbourne as its Australasia site. This new site allows Australian scientists to contribute to Target 2035, a global mission aiming for a pharmacological tool for every human protein by 2035. A major part of Target 2035 involves generating data to build next-gen AI tools for drug discovery. SGC-Melbourne will connect Australian expertise in protein science with the global SGC network. This collaboration aims to make drug discovery more computational, speeding up future medicine identification. 🧪